Climate Change Data

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

• A voluntary partial clinical hold was implemented on a trial using Starpharma's technology due to asymptomatic reported events.

Mitigation Strategies

• The events were assessed as not related to Starpharma’s DEP® dendrimer. The hold does not impact Starpharma’s platform technology, other clinical DEP® programs, or partnerships.

Supply Chain Management

Climate-Related Risks & Opportunities

Environmental Metrics

ESG Focus Areas

• Environment
• Our People
• Products and Patient Health
• Governance

Environmental Achievements

• Implemented measures to decrease energy usage, including automatic power shut-off and energy-efficient LED lighting, resulting in a 30% reduction in printing.
• Consistently employed a contract waste collector, resulting in consistent waste and recycling amounts (42,240 kg general waste and 57,400 kg recyclables annually over three years).
• Transitioned from paper-based laboratory notebooks to e-notebooks, contributing to reduced printing.

Social Achievements

• Achieved Great Place to Work® certification for the second consecutive year.
• Maintained a low voluntary employee turnover rate of 11.8% (FY23: 12.2%).
• Implemented five internal promotions and role/title changes.

Governance Achievements

• Implemented an electronic Quality Management System (eQMS) in FY23.
• No material breaches related to its Code of Conduct during the reporting period.
• No investigations or findings related to breaches of anti-bribery and anti-corruption laws.

Climate Goals & Targets

Environmental Challenges

• Relatively low annual water usage makes setting a target to lower consumption currently infeasible.
• Managing potential material risks and opportunities arising from a changing global climate and environmental landscape.

Mitigation Strategies

• Educating employees on efficient water use and consumption.
• Incorporating climate-related risks into broader risk management processes, monitored by the Audit and Risk Committee and overseen by the Board.
• Implementing control measures to prevent, reduce, or mitigate downside risks and increase the likelihood of opportunities being realized.

Supply Chain Management

Supplier Audits: Regular on- and off-site audits of key suppliers

Responsible Procurement

• Supplier Code of Conduct addressing modern slavery, anti-bribery, fair competition, health and safety, environment, data privacy, confidentiality, conflicts of interest, and insider trading.

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: UN Sustainable Development Goals, Ten Principles of the UN Global Compact, SASB Biotechnology and Pharmaceuticals Industry Standard

Certifications: ISO 13485 (Product Manufacturing), Great Place to Work®

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Goal 3: Good Health and Well-being
• Goal 8: Decent Work and Economic Growth
• Goal 13: Climate Action

Innovating and developing sustainable products, improving health and wellbeing, facilitating employment opportunities, complying with good governance procedures, and abiding by commitments to governance, environment, and gender equality.

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Great Place to Work® Certification